Gland Pharma Limited

Aditya Birla Sun Life Mutual Fund bought 90,000 shares of Gland Pharma Limited for ₹25.44 Cr at ₹2826.60 apiece in a block deal.

A vertically integrated injectable-focused pharmaceutical company, Gland Pharma develops, manufactures, and markets complex injectables for global markets across the United States, Europe, Canada, Australia, and India. Established in Hyderabad in 1978, the company operates on a business-to-business model and serves customers in over 60 countries worldwide. Known for its expertise in complex injectable formulations, it maintains a strong presence across the value chain. Gland Pharma is promoted by Shanghai Fosun Pharma, a global pharmaceutical major.

Joint venture between Aditya Birla Capital and Sun Life Financial of Canada. Among India's top five AMCs with over Rs 6.5 lakh crore in AUM across 100+ schemes. MD and CEO A. Balasubramanian is one of the most outspoken fund industry voices in India. CIO Mahesh Patil oversees the equity book with a consistent large and multicap tilt.